Alembic Pharma Share Price

₹ 1,017.30

+₹7.30 (0.72%)
1D
Last updated 09 Nov, 2026, 15:59 IST
NSE: APLLTD
|
Pharmaceuticals

Alembic Pharma Share Price Today

As of 10 Nov 2026, Alembic Pharma share price is ₹1,017.30. The stock opened at ₹1,015.10, compared to its previous close of ₹1,010.00. During today's trading session, Alembic Pharma share price moved in the range of ₹1,006.30 to ₹1,055.70, with an average price of ₹1,031.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹635.80 and a high of ₹1,055.70. On the performance front, Alembic Pharma share price has increased by 29.25% over the last six months and is up 10.34% on a year-on-year basis.

Share price over the last 1 day rose from 1015.05 to 1019.00, ranging between 1012.70 and 1054.85.
₹1,006.30
0.72% up today
₹1,055.70
1D LOW
1D HIGH

Alembic Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 97.40% QoQ
Latest Earning
Net Profit TrendUp by 93.72% QoQ
Latest Earning
Revenue TrendUp by 20.97% QoQ
Stock Performance
OutperformingBeat Nifty by 15.15 % in last 1 month
Shareholding Pattern
DIIDII decreased stake by 3.77%
Shareholding Pattern
FIIFII increased stake by 8.75%
Technical Indicators
Price breakoutPrice has broken above resistance on 1 Day interval.
Alembic Pharma stock performance
Open₹1,015.10
High₹1,055.70
Low₹1,006.30
Prev. close₹1,010.00
Alembic Pharma trading activity
Volume9,80,734
Average traded price₹1,033.45
Last traded time03:59:53 09 Nov
Last traded quantity17
Circuit
L
H
₹808.00
₹1,212.00
52-week
L
H
₹635.80
₹1,055.70
Mkt Cap Cr
19,823.39
P/E
23.61
P/B
3.33
ROA
8.81%
ROE
14.2%
ROCE
13.66%
Quick Ratio
0.78
EV/EBITDA
14.28

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Alembic Pharma outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Alembic Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Alembic Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,59,496.6441.825.159.61%13.79%18.65%2.3123.35
Divis Laboratories2,94,145.8287.4716.3413.32%15.32%19.56%3.562.27
Torrent Pharmaceuticals1,81,473.5086.469.884.7%11.42%11.37%0.7534.53
Laurus Labs1,28,054.0096.1121.1311.58%22.11%20.91%0.6853.3
Zydus Lifesciences1,19,700.4627.824.37.63%15.1%14.86%0.9116.0
Dr. Reddy's Laboratories1,14,532.4441.432.954.79%7.21%8.58%1.3519.35
Cipla1,13,988.9739.953.226.6%8.18%10.8%2.521.52
Mankind Pharma1,04,913.4547.036.057.82%12.76%14.68%0.7425.47
Aurobindo Pharma1,03,395.4126.062.646.46%10.13%12.76%1.1512.49
Lupin91,229.9517.473.7913.08%21.65%24.54%1.4210.19

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Alembic Pharma Company Background

ISIN
INE901L01018
Sector Market Cap
₹ 19,823.39 Cr

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.

Alembic Pharma Financial Highlights

  • Revenue: Alembic Pharma reported revenue of ₹7,399.31 crore in FY26 vs ₹6,714.63 crore in FY25. It showed an increase of 10.20% on a yearly basis.
  • Operating Profit: Alembic Pharma reported an operating profit of ₹693.95 crore in FY26 vs ₹707.18 crore in FY25. It showed a decrease of 1.87% on a year-on-year basis.
  • Net Profit: Alembic Pharma reported a net profit of ₹670.83 crore in FY26 vs ₹582.01 crore in FY25. It showed an increase of 15.26% on a yearly basis.

Alembic Pharma Quarterly Result Highlights

  • Alembic Pharma reported revenue of ₹2,618.59 crore in Sep 2026, compared with ₹2,164.70 crore in Jun 2026, representing an increase of 20.97% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported an operating profit of ₹437.95 crore in Sep 2026, compared with ₹221.86 crore in Jun 2026, representing an increase of 97.40% on a quarter-on-quarter (QoQ) basis.
  • Alembic Pharma reported a profit of ₹333.90 crore in Sep 2026, compared with ₹172.36 crore in Jun 2026, reflecting an increase of 93.72% on a QoQ basis.
  • The earnings per share (EPS) of Alembic Pharma stood at ₹34.33 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
69.87%
FII
4.55%
Other DII
6.93%
Retail and other
10.15%
Mutual funds
8.50%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.24%
Mar 20264.25%
Jun 20264.18%
Sep 20264.55%

Alembic Pharma Investment Returns

1 day
+0.72%
1 week
+26.72%
1 month
+27.01%
1 year
+10.34%
3 years
+38.56%
5 years
+30.36%

Alembic Pharma Share Price History

Alembic Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
09 Nov 26
₹1,015.10 / ₹1,017.30
+0.72%
08 Nov 26
₹968.00 / ₹1,010.00
+4.65%
06 Nov 26
₹894.80 / ₹965.15
+8.02%
05 Nov 26
₹919.70 / ₹893.50
-1.46%
Show more

Alembic Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹7,344.90₹6,672.08₹6,228.63₹5,652.62
Other Income₹54.41₹42.55₹28.30₹2.74
Total Revenue₹7,399.31₹6,714.63₹6,256.93₹5,655.36
Total Expenses₹6,638.62₹6,021.20₹5,624.13₹5,269.86
Profit Before Tax₹693.95₹707.18₹631.83₹354.59
Tax₹23.12₹125.17₹16.01₹12.60
Profit After Tax₹670.83₹582.01₹615.82₹341.99
EPS - Basic₹34.33₹29.68₹31.33₹17.40
EPS - Diluted₹34.33₹29.68₹31.33₹17.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹693.95₹707.18₹631.83₹354.59
Income before WC changes₹1,143.26₹1,080.71₹918.69₹842.20
Change in Assets-₹265.52-₹1,088.66-₹146.81₹38.70
Change in Liabilities₹8.70₹167.30₹51.17-₹96.26
Change in WC-₹256.82-₹921.36-₹95.64-₹57.56
Cash flow from Operations₹782.73₹87.96₹803.20₹723.95
Cash flow from Investing-₹506.06-₹568.41-₹320.61-₹447.60
Cash flow from Financing-₹163.78₹443.72-₹437.86-₹261.96
Total Cash Flow₹112.89-₹36.73₹44.73₹14.39
Cash (Start of the year)₹83.48₹120.21₹75.48₹61.09
Cash (End of the year)₹196.37₹83.48₹120.21₹75.48

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,219.99₹3,685.15₹3,367.02₹3,272.81
Current Assets₹4,542.59₹4,087.80₹3,078.56₹2,910.02
Total Assets₹8,762.58₹7,772.95₹6,445.58₹6,182.83
Current Liabilities₹2,593.83₹2,412.35₹1,454.99₹1,636.93
Net Current Asset₹1,948.76₹1,675.45₹1,623.57₹1,273.09
Non-Current Liabilities₹499.77₹171.08₹172.39₹175.43
Equity Capital₹5,668.98₹5,189.52₹4,818.20₹4,370.47
Total Equity & Liabilities₹8,762.58₹7,772.95₹6,445.58₹6,182.83

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,651.38₹6,032.63₹5,874.06₹5,149.00
Other Income₹55.90₹47.88₹31.32₹3.55
Total Revenue₹6,707.28₹6,080.51₹5,905.38₹5,152.55
Total Expenses₹5,986.18₹5,484.79₹5,201.15₹4,806.62
Profit Before Tax₹654.11₹608.59₹704.23₹345.93
Tax₹13.69₹105.47₹37.75-₹0.80
Profit After Tax₹640.42₹503.12₹666.48₹346.73
EPS - Basic₹32.58₹25.60₹33.91₹17.64
EPS - Diluted₹32.58₹25.60₹33.91₹17.64

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹654.11₹608.59₹704.23₹345.93
Income before WC changes₹1,082.56₹973.66₹988.44₹794.42
Change in Assets-₹184.71-₹828.50-₹224.36₹33.82
Change in Liabilities-₹8.84₹127.07₹18.72-₹44.21
Change in WC-₹193.55-₹701.43-₹205.64-₹10.39
Cash flow from Operations₹809.47₹226.56₹772.77₹730.25
Cash flow from Investing-₹483.43-₹636.07-₹329.02-₹460.98
Cash flow from Financing-₹317.60₹403.61-₹445.29-₹261.16
Total Cash Flow₹8.44-₹5.90-₹1.54₹8.11
Cash (Start of the year)₹14.23₹20.13₹21.67₹13.56
Cash (End of the year)₹22.67₹14.23₹20.13₹21.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,150.24₹3,790.07₹3,409.99₹3,350.19
Current Assets₹4,001.00₹3,766.19₹2,988.56₹2,780.23
Total Assets₹8,151.24₹7,556.26₹6,398.55₹6,130.42
Current Liabilities₹2,356.15₹2,199.59₹1,327.22₹1,551.30
Net Current Asset₹1,644.85₹1,566.60₹1,661.34₹1,228.93
Non-Current Liabilities₹179.83₹161.93₹162.42₹164.83
Equity Capital₹5,615.26₹5,194.74₹4,908.91₹4,414.29
Total Equity & Liabilities₹8,151.24₹7,556.26₹6,398.55₹6,130.42
* All values are in INR Crore
Alembic Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
1171017.300
0000
0000
0000
0000
Total bid quantity117
Total ask quantity0
Alembic Pharma technical summary
Bearish indicators4
Neutral indicators2
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
82.48
Bullish
ATR (14)
40.77
Neutral
STOCH(9,6)
89.38
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
46.78
Bearish
UO(9)
60.2
Neutral
ROC(12)
29.27
Bullish
WillR(14)
-9.97
Bearish
Period
Simple value
Exponential vaue
5D
915.63
930.29
10D
852.35
881.22
20D
818.55
846.6
50D
824.1
826.72
100D
818.99
811.05
Volume trend — traded volume by day
9 Nov9L
8 Nov2L
6 Nov23L
5 Nov19L
4 Nov41L
3 Nov0L
Average16L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Alembic Pharma
Pharmaceuticals
Add Stock
Add Another

Alembic Pharma Returns Calculator

Ex-date: 29 Jul 2026

Alembic Pharma Latest News

5 months ago
Alembic Pharmaceuticals shares jump 3% as US FDA tentatively approves Larotrectinib capsules
Showing news item 1 of 1

Top Gainers

CHEMPLASTS Share Price
₹237.83
+24.42 (+11.44%)
DATAPATTNS Share Price
₹4025.00
+321 (+8.67%)
QUESS Share Price
₹345.70
+27.15 (+8.52%)
SPARC Share Price
₹210.80
+13.77 (+6.99%)
GLAXO Share Price
₹2710.00
+170.4 (+6.71%)
See more

Top Losers

RRKABEL Share Price
₹1969.40
-146 (-6.9%)
FINCABLES Share Price
₹1232.40
-76.6 (-5.85%)
ALIVUS Share Price
₹1474.40
-84.3 (-5.41%)
TTML Share Price
₹39.33
-2.18 (-5.25%)
STLTECH Share Price
₹670.95
-35.3 (-5%)
See more

Alembic Pharma Share Price FAQs

Please be aware that Alembic Pharma stock prices are subject to continuous fluctuations due to various factors.